chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 78-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Arthritis" (unspecified if ongoing); "BPH" (unspecified if ongoing); "Degen. disc dis" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Tetracycline, reaction(s): "known allergies"; Ketoconazole, reaction(s): "known allergies". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16Apr2023) Positive; (unspecified date) Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid treatment from 07Apr2023 to 11Apr2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.
Patient received her COVID-19 booster on 11/5/21. She developed mild throat itchiness about 10 minutes after receiving the vaccine. Patient took 25 mg of benadryl without any improvement. She denies SOB, CP, chest tightness, throat tightness, trouble swallowing, facial swelling, or rashes. She was evaluated, treated with Pepcid and discharged.
Patient complained of redness, pain, and swelling to entire upper left arm which has since subsided. Used ice and no longer painful but complaining of a lump "the size of a quarter" now in left deltoid where she received the vaccine. Instructed patient to go in to see PCP to have checked out.
I received the vaccination on 1/14 and started to get an itching sensation that night - nothing noticeably or concern and was able to go to sleep. The next morning I was very itchy and red and started to break out in hives that started to get worse and spread through my body. I took Benadryl throughout the day and at night to help my sleep. On Saturday morning my eyes were swollen and red, I had severe hives all over my body and had to go to the ER for some type of relief. This was immediately after I woke up, the right side of my body was extremely hot and I went to the restroom and looked in the mirror and didn't recognize myself. At the ER, they put me on Prednisone - to take 2 tablets for 3 days, Famotidine - taking 1 tab, 2 times a day for 5 days, and Benadryl, 1 tab, 3X a day until the symptoms subside - It is currently 1/19 and my skin will start to heat up, primarily in my hands and start to itch, but no more hives or anything severe.  I am currently pregnant with my first child, due date 7/7/2021. I have had no previous pregnancies, miscarriages, or abortions.
Headaches leading into very high pitch noise in my head... have seen my Dr. she had MRI DONE.... she then referred to Neurologist.. she had MRA  and MRV done I?d head and neck ( With contrast ) also have appt with ENT
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with a dose of VARIVAX (Merck) (Lot # not provided). It was reported that the patient experienced a case of breakthrough chicken pox after the vaccine was administered. At the time of this report, the patient's outcome was unknown. The patient sought medical attention at the physician's office. Additional information has been requested.
Rash; Fast heart beat; This is a spontaneous report from a contactable consumer. A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 20Feb2021 (at the age of 71 years old) at a single dose for covid-19 immunisation; and paracetamol (TYLENOL), via an unspecified route of administration from an unspecified date at unknown dose and frequency for an unspecified indication. Medical history included high blood pressure, rheumatoid arthritis, tinnitus, vertigo, blood cholesterol. Concomitant medications included amlodipine for high blood pressure, lovastatin for blood cholesterol, meclizine [MECLOZINE] for vertigo, dipyridamole for tinnitus, prednisone for rheumatoid arthritis, and folic acid. On 21Feb2021, the patient experienced rash (hospitalization) and fast heart beat. "If this is the reaction, I guess I shouldn't take the second dose, right? I just think that I am not going to take second dose." Both the events required emergency room visit. The patient underwent lab tests and procedures which included blood work, electrocardiogram (EKG) and x-ray and everything came back normal on 21Feb2021. Therapeutic measure was taken as a result of the rash which included hydrocortisone. The action taken in response to the events with paracetamol was unknown. Outcome of both events was recovering.   Information on the batch/lot number has been requested.
Blister; Morbilliform Rash; streptococcal pharyngitis;  Information has been received from a licensed practical nurse concerning an unidentified female patient who on 29 Aug 2000 was vaccinated with a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation.  On 18 sep 2000 the patient developed blisters on her hands, feet and in her mouth and was seen by the physician.  The patient also had a sore throat which was positive for strep and she was placed on amoxicllin at that time.  She returned to the physician on 26 Sep 2000 with a measles like rash that the physicain felt might be a reaction to the amoxicillin.  Additonal information has been requested.
I feel a dull ache/i was awaken by the pain; This spontaneous case was reported by a patient and describes the occurrence of PAIN (I feel a dull ache/i was awaken by the pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (I feel a dull ache/i was awaken by the pain). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN (I feel a dull ache/i was awaken by the pain) outcome was unknown. Not Provided          Concomitant medication was not provided.   This case was linked to MOD-2021-020901 (Patient Link).
Within seven hours of the vaccines, he developed fever to 101.7 and had two febrile seizures within 15 minutes of each other. Child evaluated at Emergency Room. Antipyretics given.
This case was reported by a physician via sales rep and described the occurrence of myalgia in a 18-year-old female patient who received BEXSERO for prophylaxis. On an unknown date, the patient received the 1st dose of BEXSERO .5 ml. On an unknown date, unknown after receiving BEXSERO, the patient experienced myalgia and malaise. On an unknown date, the outcome of the myalgia and malaise were unknown. It was unknown if the reporter considered the myalgia and malaise to be related to BEXSERO. Additional details were provided as follows: The patient received BEXSERO on an unknown date (event happened a couple years back). The healthcare professional reported that the patient reported myalgia and malaise following administration of BEXSERO. The adverse event were resolved after a day later. This events were occurred a couple years back healthcare professional did not know exact date. The healthcare professional did not report this previously because it is a known adverse event.
This spontaneous prospective pregnancy report as received from a patient's friend refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with (Oka/Merck) VARIVAX (dose, lot # and route of administration not reported). On an unknown date, the patient became pregnant. The Last Menstrual Period (LMP) and Estimated Date of Delivery (EDD) were not known. The pregnancy outcome was pending. The trimester of exposure was unknown. No adverse effects were reported. Additional information is not expected.
persistent headache; This spontaneous case was reported by a health care professional and describes the occurrence of HEADACHE (persistent headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced HEADACHE (persistent headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (persistent headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Difficulty breathing leading to calling 911. 3 years post vaccine still trouble breathing at times, now new onset chest pain and pressure. Never had any of these symptoms until vaccine.
This spontaneous report as received from a Medical Assistant refers to a 12 month old male patient. On 14-JAN-2016, the patient was vaccinated with a expired dose of MMR II 0.5 ml, frequency: one time, lot # J009382, expiration date 08-AUG-2015, subcutaneously for prevention. There was no concomitant medication reported. No adverse event was reported due to the administration of the expired vaccine. It was unknown if the patient would continue to receive MMR II and the outcome of the receiving an expired dose of MMR II and the outcome of the receiving an expired dose of MMR II was unknown. Additional information has been requested.
Woke up with extreme dizziness to the point of almost losing balance and passing out.  Mild  nauseous, and brief cold chills.  Subsided after about 5 minutes.
Initial report received from a healthcare professional on 03 October 2013. A 45-year-old male patient had received first dose of FLUZONE ID (batch number: UT4719AA, expiry date 01 Apr 2014 and route of administration was not reported) in the left deltoid on 02 October 2013. The patient had no illness at time of vaccination, the patient developed headache and some swelling under his eyes. Laboratory tests were not reported and the patient had received ADVIL as corrective treatments. At the time of this report the patient did not recover. List of documents held by sender: None
Head ache starting at 4 pm day of shot, still having head aches Body aches Starting at 4 pm same day as shot , progressively got worse for two days. Better now. Fever on second day , lasted about one day. Nausea and vomiting on the third day after shot. Weak and tired from second day on, still experiencing fatigue.
Yesterday 2/21/21 started having itching on her arm, round area when she looked in the mirror at the time of her vaccine.  Area is warm, very itchy and 1 1/2" x 1 1/2" in size.  The area is also red today, intensely itchy.  Did put cortisone cream on it yesterday, which didn't make it go away, possibly reduced the itching some, but not much.  She does also have a headache today.  She takes a lot of vitamins, and has not taken anything else for the reactions.
The veins going down the arm feel swollen; The veins going down the arm feel tender to the touch; When I stretch my arm out I feel the pain down my veins; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (The veins going down the arm feel swollen), MYALGIA (The veins going down the arm feel tender to the touch) and PAIN IN EXTREMITY (When I stretch my arm out I feel the pain down my veins) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (The veins going down the arm feel swollen), MYALGIA (The veins going down the arm feel tender to the touch) and PAIN IN EXTREMITY (When I stretch my arm out I feel the pain down my veins). At the time of the report, PERIPHERAL SWELLING (The veins going down the arm feel swollen), MYALGIA (The veins going down the arm feel tender to the touch) and PAIN IN EXTREMITY (When I stretch my arm out I feel the pain down my veins) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported No treatment medication were reported
EVERY SINCE I RECEIVED THE SHOT A MONTH LATER KEEP GETTING ITU INFECTIONS STILL UP TO THIS DAY 06/03/2023
Patient reported feeling dizziness, his vision went black and he lost hearing within 5 minutes of receiving the vaccine. He was sweating and felt cold and tingling. Patient states the tingling started in his feet and worked its way up his entire body. Paramedics were called.
Swelling in lymph node of left arm; Rash on neck and face; Little pimple like bumps; This is a spontaneous report from a non-contactable consumer (patient).  A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left on 25Feb2021 09:30 (lot number: EL9262; expiry date: unknown) at the age of 46-years-old, as dose 2, single, for Covid-19 immunisation. Medical history included Colitis and Hashimoto's. The patient had no known allergies. Concomitant medications included cetirizine hydrochloride (ZYRTEC R); mesalazine (APRISO); and doxycycline taken for unspecified indications, start and stop date were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04Feb2021 at 10:00 AM (lot number: EL9264; expiry date: unknown) in left arm, at the age of 46-years-old, as dose 1, single for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The patient was not diagnosed with COVID prior vaccination. The patient has not been tested for COVID-19 since vaccination. On 27Feb2021, the patient experienced rash on neck and face, little pimple like bumps and swelling in lymph node of left arm. The patient did not receive treatment for the events. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Fever 102 F; Chills; Pain Injection Site; Headache; Body Aches.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 102 F), CHILLS (Chills), INJECTION SITE PAIN (Pain Injection Site), HEADACHE (Headache) and MYALGIA (Body Aches.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PYREXIA (Fever 102 F), CHILLS (Chills), INJECTION SITE PAIN (Pain Injection Site), HEADACHE (Headache) and MYALGIA (Body Aches.). At the time of the report, PYREXIA (Fever 102 F), CHILLS (Chills), INJECTION SITE PAIN (Pain Injection Site), HEADACHE (Headache) and MYALGIA (Body Aches.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
On 4/11/2007, patient reported to me that after her 1st Gardisil vaccine on 01/02/2007, she had a "blackout" feeling as she was leaving the office.  This occurred again after the 2nd Gardisil vaccine was given on 3/28/2007.She stated that "everything went black" and she could not see.  She was very much alert and could hear, at that time.  This episode lasted approximately 1 minute.  These episodes have happened recurrently since that time, initially about once a week, now occurring less often.
Sedation, NauseaVomiting,  Chills,Sweats,  Narrative:  Pt developed fatigue, nausea, chills, sweats and a headache with 2nd injection. Missed work x 105 days. No Known prior covid infection.
Guardian reported on 6/2/23 patient has swelling, redness and itchiness on administration area of vaccine. Guardian reported Benadryl was given to alleviate symptoms. Advised grandmother to take patient to ER for further evaluation.
Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST POSITIVE (Tested positive for COVID-19) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No medical history reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced SARS-COV-2 ANTIBODY TEST POSITIVE (Tested positive for COVID-19). At the time of the report, SARS-COV-2 ANTIBODY TEST POSITIVE (Tested positive for COVID-19) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant drug information was not provided. Treatment was unknown.
THE PATIENT RECEIVED THE VACCINE AT 2:00PM, AFTER THAT, AT 2:15PM THE PATIENT BEGINS TO FEEL ITCHING ON THE BODY AND THE TONE OF THE SKIN TURN FROM WHITE TO RED/PURPLE. THE PATIENT  ALSO REFERED TO EXPERIMENT SHORTNESS OF BREATH. A REGISTERED NURSE IMMEDIATELY ADMINISTERED BENADRYL 50MG IM. AT 2:30 PM THE PATIENT INFORMED THAT SHE WAS ABLE TO BREATHE. A FAMILIAR PICKED HER UP AT THE FACILITY.
Broke out in hives on crotch area, arm pits, stomach, feet, palms of my hand, legs, head. I took benedryl for 2 days, bathed with oatmeal soap, cortisol cream, put on coconut oil. The doctor then prescribed steroids (presidone) - a 5 day, 2x a day treatment with Allegra. So I was taking Benadryl 2-3 times a day, Allegra once a day, with the Presidone and cortisone cream. When the benedryl wore off, the hives would flare up. I'm trying to follow a low histamine diet and just take Allegra. I might switch to Zyrtec. I developed acid reflux/heart burn sensation on on 1/10 and have had it for 24 hours with no real relief. I took Pepcid this morning which made it worse, and tried Prilosec this evening (1/11).
Fever, chills, body aches, radiating pain in extremities: 24 hours; headache, occasional shooting pain throughout body, fatigue: ongoing since evening of 21st
This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the right arm on 04Mar2021 at 09:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included low back pain (CLBP), hip pain, atrioventricular nodal re-entrant tachycardia (AVNRT), breast cancer, skin cancer, allergy to peanuts and nickel. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included diltiazem (MANUFACTURER UNKNOWN) and meloxicam (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received morphine and derivatives (MANUFACTURER UNKNOWN) and experienced drug allergy. On 05Mar2021 at 03:00, the patient experienced sudden involuntary and sustained (5 min) contraction of all muscles in both lower legs and soreness in both legs which persisted for 15 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sudden involuntary and sustained (5 min) contraction of all muscles in both lower legs and soreness in both legs which persisted for 15 hours were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Swollen, hard, redness, stiffness, aching.  Warmth at injection site.  Has not improved since symptoms began, taking naproxen for pain relief.
red or warm around the injection site; Feels a little sore; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red or warm around the injection site) and PAIN (Feels a little sore) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A, 017B21A, 033F21A and 056M21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (red or warm around the injection site) and PAIN (Feels a little sore). At the time of the report, ERYTHEMA (red or warm around the injection site) and PAIN (Feels a little sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-746010 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-746010:Monovalent case